258 related articles for article (PubMed ID: 33002071)
21. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.
Li C; Chen K; Shi G; Shi R; Wu Z; Yuan X; Watson V; Jiang Z; Mai H; Yang T; Wang D; Chen T
BMC Med; 2022 Jun; 20(1):208. PubMed ID: 35718771
[TBL] [Abstract][Full Text] [Related]
22. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
; Lewis CE; Fine LJ; Beddhu S; Cheung AK; Cushman WC; Cutler JA; Evans GW; Johnson KC; Kitzman DW; Oparil S; Rahman M; Reboussin DM; Rocco MV; Sink KM; Snyder JK; Whelton PK; Williamson JD; Wright JT; Ambrosius WT
N Engl J Med; 2021 May; 384(20):1921-1930. PubMed ID: 34010531
[TBL] [Abstract][Full Text] [Related]
23. Aggressive systolic blood pressure control in older subjects: benefits and risks.
Chrysant SG
Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
[TBL] [Abstract][Full Text] [Related]
24. Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT).
Wang KM; Stedman MR; Chertow GM; Chang TI
Hypertension; 2020 Dec; 76(6):1725-1733. PubMed ID: 33131314
[TBL] [Abstract][Full Text] [Related]
25. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
26. Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial.
Oxlund CS; Pareek M; Rasmussen BSB; Vaduganathan M; Biering-Sørensen T; Byrne C; Almarzooq Z; Olsen MH; Bhatt DL
Am J Med; 2019 Jul; 132(7):840-846. PubMed ID: 30721655
[TBL] [Abstract][Full Text] [Related]
27. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
[TBL] [Abstract][Full Text] [Related]
28. Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT.
Mezue K; Goyal A; Pressman GS; Matthew R; Horrow JC; Rangaswami J
J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1247-1252. PubMed ID: 29984884
[TBL] [Abstract][Full Text] [Related]
29. Impact of cumulative SBP and serious adverse events on efficacy of intensive blood pressure treatment: a randomized clinical trial.
Rueda-Ochoa OL; Rojas LZ; Ahmad S; van Duijn CM; Ikram MA; Deckers JW; Franco OH; Rizopoulos D; Kavousi M
J Hypertens; 2019 May; 37(5):1058-1069. PubMed ID: 30444838
[TBL] [Abstract][Full Text] [Related]
30. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
31. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
[TBL] [Abstract][Full Text] [Related]
32. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
33. Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
Kario K; Iwashita M; Okuda Y; Sugiyama M; Saito I; Kushiro T; Teramukai S; Shimada K
Hypertension; 2018 Oct; 72(4):854-861. PubMed ID: 30354719
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological treatment of high-normal blood pressure (prehypertension) in high-risk patients for primary prevention of cardiovascular events.
Borazjani R; Kojuri J; Abdi-Ardekani A; Izadpanah P; Dehghani P; Sayadi M; Attar A
J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1627-1634. PubMed ID: 32815661
[TBL] [Abstract][Full Text] [Related]
35. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM;
Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340
[TBL] [Abstract][Full Text] [Related]
36. [SPRINT study: far lower systolic blood pressure].
Souček M; Řiháček I; Novák J
Cas Lek Cesk; 2016; 155(4):9-12. PubMed ID: 27481195
[TBL] [Abstract][Full Text] [Related]
37. Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.
Byrne C; Pareek M; Vaduganathan M; Biering-Sørensen T; Qamar A; Pandey A; Olesen TB; Olsen MH; Bhatt DL
Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):356-363. PubMed ID: 31529024
[TBL] [Abstract][Full Text] [Related]
38. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
[TBL] [Abstract][Full Text] [Related]
39. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
40. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
Widimský J
Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
